Qualisure Diagnostics Inc.
PrivateLast Round
Early Funding
Sep 1, 2026
Total Funding Raised
$1.46M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Qualisure Diagnostics Inc. operates in Healthcare & Life Sciences and is based in Calgary. Its latest recorded funding round was an Angel round in March 2024.
Qualisure Diagnostics Inc. is a biotechnology company that develops molecular diagnostic tests and software platforms to enhance cancer care by identifying features that help oncologists personalize treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qualisure Diagnostics Inc. Comparables
Compare Qualisure Diagnostics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoHelix Inc. | 87% | |
| GeneproDX | 77% | |
| Interpace Biosciences, Inc. | 76% |
For institutional investors. Book with your work email.
Qualisure Diagnostics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 1, 2026 | ||||
| Early Funding | Sep 30, 2025 | ||||
| Angel | Mar 14, 2024 | ||||
| Grant | Mar 15, 2023 | ||||
| Convertible Debt | Nov 1, 2022 | ||||
Grant | Mar 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Qualisure Diagnostics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leva Capital | Convertible Debt |
| University of Calgary Department of Oncology | Grant |
| Alberta Innovates | Grant |
| Innovate Calgary | Seed |
| Startup TNT | Convertible Debt, Grant, Angel |
| University of Calgary | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Raised $7M in early funding.
- Mar 14, 2024
Raised an Angel round with Startup TNT.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withAug 21, 2026
On Aug 21st '26, Qualisure Diagnostics Inc. and Invitrocue announce a strategic collaboration to introduce Thyroid GuidePx(R), an RNA-based diagnostic for papillary thyroid cancer, in Singapore and the broader ASEAN region.
- launchesAug 21, 2026
On Aug 21st '26, Qualisure Diagnostics Inc. announces a strategic collaboration with Invitrocue to introduce Thyroid GuidePx(R), an RNA-based diagnostic that analyzes tumor gene expression to support treatment planning for papillary thyroid cancer in Singapore and the broader ASEAN region.
For institutional investors. Book with your work email.
Qualisure Diagnostics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qualisure Diagnostics Inc.'s valuation, stock price, and market status.
Is Qualisure Diagnostics Inc. a public or private company?
Qualisure Diagnostics Inc. is a private company.
What is the current stock price of Qualisure Diagnostics Inc.?
Qualisure Diagnostics Inc. is a private company, so its shares have no public market price. Caplight tracks Qualisure Diagnostics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qualisure Diagnostics Inc. worth (valuation)?
Valuation information for Qualisure Diagnostics Inc. is not publicly available.
Can I buy Qualisure Diagnostics Inc. stock?
Qualisure Diagnostics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qualisure Diagnostics Inc.'s last funding round?
Qualisure Diagnostics Inc.'s most recent funding round was Early Funding on September 1, 2026.
Who are the main investors in Qualisure Diagnostics Inc.?
Key investors in Qualisure Diagnostics Inc. include Leva Capital, University of Calgary Department of Oncology, Alberta Innovates, Innovate Calgary, Startup TNT.
Will Qualisure Diagnostics Inc. IPO soon?
No public IPO plans have been announced for Qualisure Diagnostics Inc..
How can I track Qualisure Diagnostics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Qualisure Diagnostics Inc.'s shares on secondary markets.